AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Comparative Effectiveness of Myofacial Release vs Cupping Therapy on Quality of Life in Restless Leg Syndrome With Knee O.A.

RecruitingNAAges 40 Years - 70 YearsAllDow University of Health Sciences
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The aim of this study is to determine effectiveness of Myofascial Release and Cupping Therapy on Quality of Life in Restless Leg Syndrome with knee Osteoarthritis. Holding this aim, a Randomized control trial will be conducted at physiotherapy out patient department of Dow Institute of Physical Medicine and Rehabilitation. The subjects will first be screened by the principal investigator, physiotherapist, using the criteria of International Restless Leg Syndrome Study Group (IRLSSG). Each selected subject will go for random allocation in one of the two treatment groups with different interventions with the help of a computer-generated randomization sheet. The group A will be provided with myofacial release whereas the group B will receive cupping therapy while cryotherapy and passive lower limb stretches (hamstring and calf muscles) will be applied to both the groups as standard treatme

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. grade 2, 3 and 4 knee OA by the Kellgren Lawrence classification 2. Bilateral or unilateral both knee OA 3. Age 40 to 70 years 4. Patients who were meeting the International Restless Leg Syndrome Study Group (IRLSSG) eligibility criteria Exclusion Criteria: 1. patients with cognitive dysfunction 2. Rheumatoid arthritis 3. patients with neurological disorders 4. Medical conditions covering (cardiovascular disease, neurological disorders, severe psychiatric illness or pregnancy)
๐Ÿ’Š

What it tests

  • Myofacial release
  • Dynamic cupping therapy
๐Ÿ“

Where

1 site
Dow Institute of Physical Medicine and Rehabilitation
Karachi, Pakistan
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy